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Abstract 
Diabetes mellitus is a chronic debilitating problem with increasing incidence and long term complications such as 
diabetic nephropathy, diabetic neuropathy, diabetic retinopathy etc. These complications are mainly a consequence 
of macro vascular and micro vascular damages of the target organs. The magnitude of the complications of diabetes 
is related to its duration. Less has been known about the after effects of diabetes on lungs. So this work was carried 
out to know the relation between duration of diabetes and lung volumes and capacities in Type 2 DM patients. The 
presence of an extensive micro vascular circulation and abundant connective tissue in the lungs raises the possibility 
that lung tissue may be affected by Microangiopathy process and non-enzymatic glycosylation of tissue proteins, 
induced by chronic hyperglycemia, there by rendering the lung a “target organ” in diabetic patients.  This is a cross-
sectional study, the test group were Type 2 Diabetes Mellitus patients (n=50) with duration of 2-35 years, the control 
group were staff of Narayana medical college (n=50). Written consent was obtained from them. The following lung 
function parameters were recorded: Forced Vital Capacity (FVC), Forced Expiratory Volume in the first second 
(FEV1), Forced Expiratory Volume percent (FEV1/FVC %), Peak Expiratory Flow Rate (PEFR), Forced Expiratory 
Flow 25-75% (FEF25-75%), Maximum Voluntary Ventilation (MVV). The mean FVC, FEV1, PEFR, FEF25-75%, 
MVV values are low in diabetics compared to controls (p value <0.001) and the parameters showed significant 
negative correlation with duration of diabetes.  
Key words: Chronic hyperglycemia, Diabetes mellitus, Microangiopathy, Micro vascular circulation, Pulmonary 
function tests 
 
1. Introduction 
Diabetes mellitus (DM) is a complex medical syndrome comprising of heterogenous group of diseases resulting from 
diverse aetiologies predominantly of genetic and environmental origin. It is characterized by chronic hyperglycemia 
with disturbances of carbohydrate, protein and fat metabolism, resulting from defects in insulin secretion or insulin 
action or both[1].    According to WHO, the total number of people worldwide with diabetes is projected to rise from 
150 million in 2000 to 435 million in 2030 [2, 3]. India is called Diabetic Capital of World as there are going to be 
80% of all diabetics from the entire world population, concentrated here [2,3].  Greater longevity, obesity, 
unsatisfactory diet, sedentary lifestyle and increasing urbanisation are main factors contributing for this. Type 2 or 
NIDDM, is characterized by insulin resistance and impaired insulin receptors.  It is common type of diabetes and 
usually develops after the age of 40 years.  It is associated with normal B cell morphology [4] . Type 2 diabetes 
comprises 90% of people with diabetes all around the world, and is largely the result of excess body weight and 
physical inactivity [2, 3]. There is one person in the world dying of diabetes every ten seconds and new diabetic 
cases being identified every ten seconds [3].  
 
DM is accompanied by widespread biochemical, morphological and functional abnormalities which may precipitate 
certain complications that may affect neural, Cardiovascular, renal systems and also organs and tissues like skin, 
liver, collagen and elastic fibers. Thus diabetes is a multisystem disorders that affect many organs of the body [5]
 
. 
These complications are mainly a consequence of macro vascular and micro vascular damages of the target organs 
[1] . The micro vascular complications appear early within 5to10 years and macro vascular complications appear 
within 15 to 20 years from the onset of diabetes. Like other target organs lung is also affected in diabetes[1,5]. The 
presence of an extensive micro vascular circulation and abundant connective tissue in the lungs , raises the 
possibility that lung tissue may be affected by Microangiopathy process and non-enzymatic glycosylation of tissue 
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proteins, induced by chronic hyperglycemia, there by rendering the lung a “target organ” in diabetic patients. 
Hyperglycemia causes thickening of basal lamina in pulmonary capillaries leading to decreased diffusion capacity. 
The alteration  in scleroproteins in turn affect mechanical properties of lungs. In this chronic disease, the 
susceptibility and severity of systemic inflammation increases which may cause peripheral airway obstruction[1]. 
Since normal lung mechanics and gas exchange are influenced by the integrity of the pulmonary connective tissue 
and microvasulature, abnormalities in either of these two structural components of the lung may lead due to the 
development of measurable abnormalities of pulmonary function [6]. 
 
The duration of DM is an important factor affecting the lungs. Chronic hyperglycemia is strongly associated with 
progressive neurogenic damage.  In 2000,  Davis et al. observed    that  some pulmonary  functions were decreased in 
type 2 diabetes and the reduction was directly proportionate to the duration of the disease [1,7].  In 2007, Meo et al. 
also observed that some spirometric lung function parameters were  decreased in   type 2 diabetics and the decline 
was more in patients with longer duration of diabetes [1].  In a Japanese study, the incidence of pulmonary pathology 
was found to be 50% on autopsy.  It has been suggested that pulmonary dysfunction may be one of the earliest 
measurable non-metabolic alteration in diabetes. If diabetes is detected early and adequate steps are taken, it may be 
possible to significantly delay the occurrence of complications and there after their progression. Although a lot of 
research work is being carried out worldwide on the after effects of Diabetes on pulmonary function parameters, the 
literature pertaining to this is not in abundance in India. Therefore, this study was undertaken to find out the 
correlation between duration of type 2 diabetes and pulmonary function parameters. 
 
2. Materials and Methods 
This was a cross-sectional study undertaken by the Department of Physiology, Narayana medical college (NMC), 
Nellore, Andhra Pradesh, India. After obtaining approval of Institutional Ethics Committee (IEC), the test group 
subjects (n=50) type 2 diabetic patients were recruited from Out Patient Departments (OPD) and central laboratory 
of NMC and hospital. The control group subjects (n=50) were teaching and non-teaching staff of NMC. The subjects 
in the age group between 30-60 years are included. Subjects with past history of (H/O) smoking, hypertension, 
respiratory diseases, chest wall injuries, congestive cardiac failure, kyphoscoliosis, and age <30 and >60 years were 
excluded from the study. The subjects were properly explained about the objectives, methodology, expected outcome 
and implications of the study and written informed consents were obtained from them. They were instructed to report 
to Respiratory Physiology Research laboratory of Physiology department at about 9 A.M. 
     Following 5 minutes sitting rest in the lab, their pulmonary functions were assessed by computerized spirometer 
(Spiro win Version 2.0 of Genesis Medical systems pvt Ltd) which gives ERS-93 predicted values at BTPS 
conditions [8].   At the beginning, satisfactory demonstrations were given regarding the equipment and the procedure 
of the study. During the procedure, the subjects inhaled deeply and then exhaled with maximum effort as much as 
possible in to the mouth piece. The following parameters were recorded: Forced vital capacity(FVC), Forced 
expiratory volume in the first second(FEV1), Forced expiratory volume percent(FEV1/FVC%), Peak expiratory flow 
rate(PEFR), Forced expiratory flow 25-75%(FEF25-75%) and Maximum voluntary ventilation(MVV). 
 
3. Results   
The data were expressed as mean ± SD. The data was analysed by Students ‘t’ test. The p values less than 0.05 was 
considered significant. In diabetic subjects, there was significant decrease in FVC (p<0.001), FEV1 (p<0.001), 
FEV1/FVC% (p<0.01), PEFR (p<0.001), FEF25-75% (p<0.001) and MVV (p<0.001) compared to non-diabetic 
subjects. Relationship of FVC, FEV1, FEV1/FVC%, PEFR, FEF25-75%,  and MVV with duration of diabetes were 
observed. The results showed negative correlation with duration of diabetes and were statistically significant (fig.1-
6)  
4. Discussion 
Diabetes mellitus, an incurable lifelong disease, involves multiple systems with wide-ranging and devastating 
complications, which end up in severe disability and death. Despite effective interventions directed at the 
complications of diabetes mellitus, including coronary artery disease, diabetic nephropathy, retinopathy, and 
neuropathy, the pulmonary complications of diabetes mellitus have been poorly characterized[9,10]. Furthermore, 
there have been very little data reported on whether there is an association between years of disease and pulmonary 
function, and there are very few reports of pulmonary function in patients with diabetes. A study conducted by 
David. A Kaminsky in 2004 speculates that abnormal lung function may precede the diagnosis of diabetes, 
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suggesting that lung may contribute to or at least be commonly affected by factors involved in the pathogenesis of 
diabetes [5].  
 
4.1. Effect of duration of DM on FEV 
There was significant reduction in mean FVC in all diabetic patients and the reduction was more pronounced with 
increased duration of diabetes. Recent studies conducted by Lange et al. and Asanuma et al indicate that both IDDM 
and NIDDM patients are associated with slight reduction in FVC and it was because of impaired defense against 
environmental challenges such as smoking and airway infections in diabetes [11,12]. There was increased cross-
linkage formation between polypeptides of collagen in pulmonary connective tissue, which decreases FVC and hence 
is responsible for restrictive respiratory defects.   In a study by Davis A.Wendy et.al., there was a decrease in mean 
FVC values as the duration of DM increased. In their study the annual rate of fall in FVC was 68 ml [5,7]. In a study 
by Robert E. Walter et.al., there was a progressive decrease in mean FVC values by 109 ml/year [5]. A study by 
Timothy M.E Davis, showed there was an average decrease of 9.5% in mean FVC values in diabetics [13].  
 
4.2. Effect of duration of DM on FEV1 
FEV1 is the volume of air that is exhaled in the first second during FVC manoeuvre.  It is useful to detect generalized 
airway obstruction. The Mean FEV1 values showed significant negative correlation with duration of diabetes. The 
values of FVC and FEV1 in type 2 diabetic patients of different duration were significantly lower than those of non-
diabetic subjects. These findings were consistent with findings of Meo et al. and Davis et al [7]. In diabetes, there is a 
thickening of alveolar epithelium and pulmonary capillary basal lamina leading to pulmonary microangiopathy, 
reduced pulmonary elastic recoil due to non-enzymatic glycosylation of connective tissue reducing the FEV 1[9,10]. 
Patients with diabetes for more than 12 years experienced a significant reduction in FVC, FEV1, and FEF25–75% 
relative to controls [9]. A large Danish cross-sectional population study Lange P (1989) showed a negative 
association between plasma glucose & both FVC & FEV1 . The negative correlation of  FVC & FEV1 with duration 
of diabetes indicate that long standing hyperglycemia may intensify the devastating effect of the disease. In a small 
scale six years study by Ramiriez LC, et al (1991) demonstrated that intensive treatment by subcutaneous insulin 
infusion improved both FVC & FEV1 percentage predicted values[13].  
 
4.3. Effect of duration  of Type 2 DM on FEV1 /FVC% 
FEV1/FVC% is the volume of air expired in the first second, expressed as percentage of FVC.  It is a more sensitive 
indicator of airway obstruction, than FVC or FEV1 alone. The alteration in collagen and elastin ratio is the main 
factor in the diabetic patients. The decrease in FEV1/FVC% in diabetic subjects may be related with the poor 
mechanical properties of the lung, like lung compliance and elastic recoil of lungs. Loss of elastic recoil leads to 
dynamic collapse of small airways during expiration.  In addition, myopathic or neuropathic changes affecting the 
respiratory  muscles further impairs the endurance, efficiency of ventilatory pump. A study conducted by Ali Mo et 
al. showed similar findings but was not significant [1].  Sreeja et al. reported almost similar type of finding [11].        
     When FEV1/ FVC% was observed , the actual values were higher than the predicted values by 3.75%  and 7.3%  
which suggest of restrictive pattern in diabetics. In a study by Robert .E. Walter the ratio was increased by 1.5% in 
diabetics which was statistically significant [5]. This parameter was significantly higher in 10-20 years   duration of 
diabetes than 5-10 years duration and also control group, finding similar to Ali MO et al.[1,10]. 
 
4.4. Effect of duration of Type 2 DM on PEFR 
PEFR values were observed  in all the groups, there was an absolute decrease in the mean values compared to 
predicted values which was statistically significant (p<0.001). In a study by Timothy ME Davis, there was a average 
decrease in mean value of PEFR by 9.5%[5,13]. As per the study of Sreeja  et.al., the decrease in PEFR was 
267.65L/sec[11]. The patients with diabetes complicated by autonomic neuropathy have impaired control of 
bronchomotor tone.  Resting vagal tone is depressed which explains the depressed bronchoconstrictory response to 
both cholinergic stimuli and hyperventilation with cold air [12,14]. Thus, there is a complex alteration of both 
control of ventilation and bronchomotor tone in diabetic patients with automatic neuropathy[15]. 
4.5. Effect of duration of diabetes on FEF25–75% 
FEF25-75% is the average flow rate during middle 50% of FVC.  It indicates patency of the small airways.        FEF 25-
75% depends on non-bronchopulmonary factors like, neuromuscular factors and mechanical equipment factors of 
inertial distortion of lungs[15].  The thickening of alveolar wall due to the increased amounts of collagen and elastin 
Journal of Biology, Agriculture and Healthcare                                                                                                                                         www.iiste.org 
ISSN 2224-3208 (Paper)  ISSN 2225-093X (Online) 
Vol 2, No.6, 2012 
 
80 
 
in basal lamina results in microangiopathy. Chronic hyperglycemia causes fibrous tissue formation in the chest wall 
and bronchial tree protein by non-enzymatic glycation.  This may cause reduced compliance of lung and chronic 
airflow obstruction [14,15,17].There was a significant reduction in FEF 25-75% among diabetics  compared to controls, 
shows a lower airway caliber and higher airway resistance and this finding was similar to Ashapherwani et al and 
Malcom Sandler et al [14].  As per the study of Sreeja et. al., there was decrease in   FEF 25-75%  by 2.45 ± 0.55[5,11]. 
So our results coincide with the same. 
 
4.6. Effect of duration of diabetes on MVV 
 MVV is the maximum breathing capacity which is decreased in poor respiratory muscle strength, emphysema etc. 
There was a significant reduction in MVV values in diabetics compared to controls, shows poor skeletal muscle 
strength due to increased protein catabolism and diabetic autonomic neuropathy.  A study conducted by Park SW et 
al. and Meo SA et al. showed similar results. Thus, respiratory muscle endurance decreases in diabetes 
mellitus[9,11]. 
 
     Hyperglycemia causes over production of mitochordrial superoxides and reduction in anti-oxidant defence of the 
lungs [17].  The glycation of proteins can lead to oxidative stress by direct release of O2 and H2O2, and activation of 
phagocytes through a specialized receptor for advanced glycosylation end products (AGEs).  Oxidants include 
reactive oxygen species (ROS), reactive nitrogen species (RNS), sulphur centered radicals and others.  Phagocytic 
cells generate large amounts of NO and ROS.  In diabetes there are alterations in antioxidant enzymes, impaired 
glutathione metabolism, and decreased ascorbic acid levels. Nitric oxide is produced by nitric oxide synthase (NOS).  
Three different forms of NOS expressed in lungs are neuronal (n NOS),  endothelial (e NOS), and inducible (i NOS).  
Excessive NO produced by i NOS and its potent oxidative derivative peroxynitrate via oxidation, hydroxylation, and 
nitration is involved in acute lung injury  [16,17]]. 
     The alvelolar capillary network is the largest microvascular organ (Surface area 140 m
2
) and receives entire 
cardiac output[18] .  As the pulmonary reserves are larger, the symptoms and disability from diabetes develop earlier 
in other organs than in the lungs. 
     The correlation graphs reflect a relation between the duration of diabetes on FVC, FEV1, FEV1/FVC%, PEF, 
FEF25-75% and MVV.  The correlation graphs show a negative correlation between duration of diabetes and lung 
function parameter values in  diabetics.  FEV1/FVC% showed a positive correlation with duration of diabetes.  
Similar findings were observed by Ali MO et al. and Meo et al.[1,9]. 
5. Conclusion 
The correlation graphs in our study, reflect a relation between the effect of duration of diabetes on lung function 
parameters i.e; the reduction is directly proportionate to the duration of the disease.  Even though Type2 diabetic 
patients did not have any respiratory symptoms, they did have underlying subclinical restrictive patterns of lung 
functions. As the duration of diabetes increases the restrictive profile is more prominent. The findings of present 
study suggest that, lung is a target organ for damage in diabetes and the glycemic exposure is a strong determinant of 
reduced pulmonary function in type 2 diabetics.  As measures of airflow limitation predict all-cause mortality in type 
2 diabetes, intensive glycemic management may reduce the risk of death through improved ventilatory function 
independent of other beneficial effects. The lower lung function, particularly reduced vital capacity, not only 
precedes the onset of diabetes but also continues, at an accelerated pace with the onset of the disease. As pulmonary 
dysfunction may be one of the earliest and easily measurable non-metabolic alteration in diabetes, the patients with 
diabetes are suggested to undergo pulmonary function testing along with other investigations. Additional research is 
required to identify pathophysiologic mechanisms and to determine clinical significance of this association. Hence, it 
is an alarming signal to clinicians to pay heightened attention to pulmonary function in their patients with type 2 
diabetes. 
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Fig.1: A significant negative correlation was 
found, indicating that increased duration of 
disease decreased the FVC. 
Fig.2: Regression analysis for forced expiratory 
volume in 1 second against duration of disease 
in diabetic patients. A significant negative 
correlation was found, indicating that increased 
duration of disease decreased the FEV1. 
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Fig.3: A significant negative correlation was 
found, indicating that increased duration of 
disease decreased the FEV1/FVC% . 
Fig.4: There is slight negative correlation 
between duration of diabetes and PEFR 
values.                           
Fig.5:A significant negative correlation was 
found, indicating that increased duration of 
disease decreased the FEF25–75%. 
Fig.6: Graph shows a significant negative 
correlation of MVV values with duration of 
diabetes. 
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